Drug information for KEPIVANCE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION 60MCG/KG/DAY Prescription   PALIFERMIN Fibroblast Growth Factor 7 BIOVITRUM AB 125103
2011-11-22 Letter
2011-11-21 Label
2011-09-30 Label
2005-12-16 Letter
2005-12-16 Label
2005-09-26 Review
2005-07-28 Other Important Information from FDA
2004-12-29 Letter
2004-12-29 Label

Drug Adverse Effects information for KEPIVANCE

Role code Indications Reaction # Reports
PS PROPHYLAXIS DRUG HYPERSENSITIVITY 1
PS PROPHYLAXIS DRUG INTOLERANCE 1
PS PROPHYLAXIS INFECTION 1
PS PROPHYLAXIS MUCOSAL INFLAMMATION 1
PS PROPHYLAXIS MULTI-ORGAN FAILURE 1
PS PROPHYLAXIS TOXICITY TO VARIOUS AGENTS 1
PS PROPHYLAXIS TRANSPLANT FAILURE 1
PS STOMATITIS DRUG HYPERSENSITIVITY 1
PS STOMATITIS DRUG INTOLERANCE 1
PS STOMATITIS INFECTION 1
PS STOMATITIS MUCOSAL INFLAMMATION 1
PS STOMATITIS MULTI-ORGAN FAILURE 1
PS STOMATITIS TOXICITY TO VARIOUS AGENTS 1
PS STOMATITIS TRANSPLANT FAILURE 1
Ads by Google